Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
The emergence of Plasmodium falciparum parasites resistant to artemisinins compromises the efficacy of Artemisinin Combination Therapies (ACTs), the global first-line malaria treatment. Artemisinin resistance is a complex genetic trait in which nonsynonymous SNPs in PfK13 cooperate with other geneti...
Hoofdauteurs: | Nayak, S, Peto, TJ, Kucharski, M, Tripura, R, Callery, JJ, Quang Huy, DT, Gendrot, M, Lek, D, Nghia, HDT, van der Pluijm, RW, Dong, N, Long, LT, Vongpromek, R, Rekol, H, Hoang Chau, N, Miotto, O, Mukaka, M, Dhorda, M, von Seidlein, L, Imwong, M, Roca, X, Day, NPJ, White, NJ, Dondorp, AM |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
Nature Research
2024
|
Gelijkaardige items
-
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
door: Nayak, Sourav, et al.
Gepubliceerd in: (2025) -
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
door: Sourav Nayak, et al.
Gepubliceerd in: (2024-12-01) -
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
door: Peto, TJ, et al.
Gepubliceerd in: (2022) -
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
door: van der Pluijm, RW, et al.
Gepubliceerd in: (2022) -
Triple artemisinin-based combination therapies for malaria – a new paradigm?
door: van der Pluijm, RW, et al.
Gepubliceerd in: (2020)